Intellectual Property Magazine
Fine cut
Catherine White
The UK’sCompetition Appeal Tribunal (CAT) has upheld a 2016 Competition and MarketsAuthority’s (CMA) decision that GlaxoSmithKline
(GSK) and generic suppliers“broke competition law”.
The UK’sCompetition Appeal Tribunal (CAT) has upheld a 2016 Competition and MarketsAuthority’s (CMA) decision that GlaxoSmithKline
(GSK) and generic suppliers“broke competition law”.